{"relation": [["Gene", "ADRA1A", "ADRA1B", "ADRA1D", "ADRA2A", "ADRA2B", "ADRA2C", "CHRM1", "CHRM2", "CHRM3", "CHRM4", "CHRM5", "DRD2", "HRH1", "HRH2", "HTR1A", "HTR2A", "HTR2B", "HTR2C", "SLC6A2", "SLC6A4"], ["Description", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)", "(source: Drug Bank)"]], "pageTitle": "doxepin", "title": "", "url": "https://www.pharmgkb.org/drug/PA449409?tabType=tabVip", "hasHeader": true, "headerPosition": "FIRST_ROW", "tableType": "RELATION", "tableNum": 3, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989507.42/warc/CC-MAIN-20150728002309-00045-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 926420671, "recordOffset": 926388796, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Drug Targets KCNH2 VIP CYP3A4 PW CYP2D6 PW VIP VA CA DL DG CYP2C9 PW VA", "textAfterTable": "Drug Interactions Drug Description doxepin Increases the effect and toxicity of tricyclics (source: Drug Bank) doxepin Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if atazanavir if initiated, discontinued or dose changed. (source: Drug Bank) doxepin The tricyclic increases the effect of carbamazepine (source: Drug Bank) doxepin Carbamazepine may decrease the serum concentration of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if carbamazepine is initiated, discontinued or dose changed. (source: Drug Bank) doxepin Increases the effect of tricyclic agent (source: Drug Bank) doxepin Cimetidine may increase the effect of tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if cimetidine is initiated, discontinued or dose changed. (source: Drug Bank) doxepin Increased risk of cardiotoxicity and arrhythmias (source: Drug Bank) doxepin", "hasKeyColumn": true, "keyColumnIndex": 0, "headerRowIndex": 0}